In the BioHarmony Drug Report Database
Entacapone
Comtan, Comtess, Entacapone Orion (entacapone) is a small molecule pharmaceutical. Entacapone was first approved as Comtan on 1998-09-16. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against catechol O-methyltransferase. In addition, it is known to target alpha-ketoglutarate-dependent dioxygenase FTO.
Trade Name
|
Comtan, Comtess, Entacapone Orion |
|---|---|
Common Name
|
entacapone |
ChEMBL ID
|
CHEMBL953 |
Indication
|
parkinson disease |
Drug Class
|
Catechol-O-methyltransferase (COMT) inhibitors |
Image (chem structure or protein)